Up to one-third of patients with status epilepticus will not respond to benzodiazepines. Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied. The longer seizures persist, the worse patients do. In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
Respiratory distress in the patient with a tracheostomy can incite fear in even the most seasoned emergency physician or intensivist. In this episode, we...
Nearly 200,000 patients are admitted to the hospital each year in the United States for acute asthma exacerbations. Approximately 2% of patients are intubated...
Etomidate and ketamine are frequently used for RSI in critically ill patients. Recent articles have raised concern about an increased incidence of post-intubation hypotension...